Market cap
₹65 Cr
Recently Viewed
Clear AllBSE: 540788
₹63.50
₹-0.75
(-1.17%)
As on 28-Apr-2026IST
Market cap
₹65 Cr
Revenue (TTM)
₹24 Cr
P/E Ratio
44.6
P/B Ratio
5.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹1 Cr
ROE
18.1 %
ROCE
19.3 %
Industry P/E
395.23
EV/EBITDA
19.3
Debt to Equity
0.1
Book Value
₹12.5
EPS
₹1.4
Face value
10
Shares outstanding
10,293,000
CFO
₹-1.15 Cr
EBITDA
₹2.00 Cr
Net Profit
₹-12.60 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Aspira Pathlab
| -4.0 | 16.0 | -2.0 | -6.6 | 24.4 | 16.3 | -- |
|
BSE Healthcare
| 2.6 | 5.0 | 8.0 | 6.4 | 25.0 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Aspira Pathlab
| 9.0 | 52.6 | -9.0 | -44.2 | 180.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Aspira Pathlab
|
63.5 | 65.4 | 24.2 | 1.5 | 5.5 | 11 | 44.6 | 5.1 |
| 705.3 | 36,540.5 | 4,461.2 | 397.5 | 13.4 | 9.1 | 111.7 | 7.9 | |
| 9.4 | 8.1 | 4.5 | 0.4 | -- | 4.3 | 19.4 | 0.6 | |
| 1,411.7 | 23,668.0 | 2,662.8 | 533.1 | 22.9 | 24.1 | 44.8 | 9.2 | |
| 14.1 | 14.8 | 0.6 | 0.2 | -- | 0.8 | 74.2 | 0.6 | |
| 662.3 | 26,529.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 88.2 | 11.4 | |
| 120.2 | 249.4 | 51.6 | 0.7 | 1.3 | 1.1 | 381.8 | 4.1 | |
| 127.0 | 42.6 | 16.5 | -1.4 | 6.6 | -3.6 | -- | 1.1 | |
| 17.2 | 39.1 | 0.0 | -8.7 | -- | -64.3 | -- | 3.4 | |
| 70.2 | 30.0 | 27.2 | -2.0 | -3.4 | -287.5 | -- | -28.7 |
No Review & Analysis are available.
Hospital activities
Incorporated
1973
Chairman
Haseeb A Drabu
Managing Director
Pankaj Shah
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of Aspira Pathlab & Diagnostics Ltd is ₹63.50 (BSE) as of 28-Apr-2026 IST. Aspira Pathlab & Diagnostics Ltd has given a return of 24.39% in the last 3 years.
The P/E ratio of Aspira Pathlab & Diagnostics Ltd is 44.58 times as on 28-Apr-2026, a 89 discount to its peers’ median range of 395.23 times.
The P/B ratio of Aspira Pathlab & Diagnostics Ltd is 5.08 times as on 28-Apr-2026, a 19 premium to its peers’ median range of 4.28 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
43.37
|
7.21
|
|
2024
|
0.00
|
3.15
|
|
2023
|
0.00
|
2.25
|
|
2022
|
14.96
|
5.22
|
|
2021
|
21.24
|
3.53
|
The 52-week high and low of Aspira Pathlab & Diagnostics Ltd are Rs 81.00 and Rs 49.00 as of 28-Apr-2026.
Aspira Pathlab & Diagnostics Ltd has a market capitalisation of ₹ 65 Cr as on 28-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Aspira Pathlab & Diagnostics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.